1. Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; Jennifer L. Malin, WellPoint, Indianapolis, IN; Stephanie Chan and John L. Adams, RAND, Santa Monica; Douglas W. Blayney, Stanford Cancer Center, Stanford Medical Center, Palo Alto, CA; Pamela J. Kadlubek, American Society of Clinical Oncology, Alexandria, VA; Joseph O. Jacobson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joseph V. Simone, Simone Consulting, Dunwoody, GA.